The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.